| Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). | |
| | |
MedLine Citation:
|
PMID: 21548140 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Gamma-hydroxybutyrate (GHB) has been used as a recreational drug since the 1990s and over the last few years there has been increasing use of its analogues gamma-butyrolactone (GBL) and to a lesser extent 1,4-butanediol (1,4BD). This review will summarize the literature on the pharmacology of these compounds; the patterns and management of acute toxicity associated with their use; and the clinical patterns of presentation and management of chronic dependency associated with GHB and its analogues. Copyright © 2011 John Wiley & Sons, Ltd. |
| | |
Authors:
|
David M Wood; Alan D Brailsford; Paul I Dargan |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-6 |
Journal Detail:
|
Title: Drug testing and analysis Volume: - ISSN: 1942-7611 ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-6 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101483449 Medline TA: Drug Test Anal Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 John Wiley & Sons, Ltd. |
Affiliation:
|
Guy's and St Thomas' NHS Foundation Trust, London, UK and King's Health Partners London, UK. David.Wood@gstt.nhs.uk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Determination of urinary concentrations of pseudoephedrine and cathine after therapeutic administrat...
Next Document: Purification of pharmaceutical preparations using thin-layer chromatography to obtain mass spectra w...